Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.02 (+0.20%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMII) Assets (2024 - 2025)

Drugs Made In America Acquisition (DMII) posted quarterly Assets of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% quarter-over-quarter from $501.0 million in Q3 2025.

Drugs Made In America Acquisition (DMII) Assets (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Assets for 2 consecutive years, with $505.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Assets rose 365643.31% year-over-year to $505.0 million; the TTM figure through Dec 2025 stood at $505.0 million (up 365643.31% YoY), while the FY2025 annual figure was $505.0 million, up 365643.31% from the prior year.
  • Assets advanced to $505.0 million in Q4 2025 per DMII's latest filing, from $501.0 million in the prior quarter.
  • Across five years, Assets topped out at $505.0 million in Q4 2025 and bottomed at $138064.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - 245.80 Mn
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 514.10 Mn
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - 464.99 Mn
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 98.35 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - 247.73 Mn
6 Gores Holdings X 381.05 Mn 380.85 Mn - 374.60 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 376.80 Mn
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - 263.49 Mn
9 Berto Acquisition 313.96 Mn 313.81 Mn - 314.40 Mn
10 New Providence Acquisition Corp. III 313.81 Mn 313.81 Mn - 315.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 504.96 Mn
Sep 30, 2025 501.01 Mn
Dec 31, 2024 138,064.00